Evaluation of the prognostic significance of HMGB1 expression by Kaplan–Meier survival analysis using the GSE96058 dataset revealed the association of the increased HMGB1 expression with poorer overall survival in patients with breast cancer (Fig. 1A). Here, HMGB1 is linked to breast cancer.